NEOPHARM BULGARIA Ltd. announces a contractor selection procedure for the following subject:
“Supply, installation, and commissioning of an installation for the production of probiotic blends in the form of powdered active substance – 1 unit.”
Deadline for submission of offers: March 14, 2025, 23:59
The documentation for participation in the procedure can be found at the following link:
https://eumis2020.government.bg/bg/s/Offers/Details/c22432bf-d427-48c9-8408-c2dd545700ff
The procedure is announced in implementation of contract BG16RFPR001-1.003-0224-C01 “Implementation of an innovative product for the prevention and treatment of constipation in production,” co-financed through the “Competitiveness and Innovation in Enterprises” Program 2021-2027, under the “Implementation of Innovations in Enterprises” procedure.
“Supply, installation, and commissioning of an installation for the production of probiotic blends in the form of powdered active substance – 1 unit.”
Deadline for submission of offers: March 14, 2025, 23:59
The documentation for participation in the procedure can be found at the following link:
https://eumis2020.government.bg/bg/s/Offers/Details/c22432bf-d427-48c9-8408-c2dd545700ff
The procedure is announced in implementation of contract BG16RFPR001-1.003-0224-C01 “Implementation of an innovative product for the prevention and treatment of constipation in production,” co-financed through the “Competitiveness and Innovation in Enterprises” Program 2021-2027, under the “Implementation of Innovations in Enterprises” procedure.
Project: BG16RFOP002-1.005-0150, “Innovation and Development in Neopharm Bulgaria Ltd.”
Major objective: Promoting innovation and research at Neopharm Bulgaria Ltd.
Beneficiary: Neopharm Bulgaria Ltd.
Partner: Institute of Microbiology “Stefan Angelov” – Bulgarian Academy of Sciences
Total value: BGN 436 038.00, of which BGN 320 514.70 grant, as follows: BGN 272 437.50 European and BGN 48 077.20 national co-financing
Start: 16.11.2018
End: 16.11.2020
Major objective: Promoting innovation and research at Neopharm Bulgaria Ltd.
Beneficiary: Neopharm Bulgaria Ltd.
Partner: Institute of Microbiology “Stefan Angelov” – Bulgarian Academy of Sciences
Total value: BGN 436 038.00, of which BGN 320 514.70 grant, as follows: BGN 272 437.50 European and BGN 48 077.20 national co-financing
Start: 16.11.2018
End: 16.11.2020
Проект: BG16RFOP002-2.077-0600
Primary objective: Supporting medium-sized enterprises to overcome the economic consequences of the COVID-19 pandemic, Providing operating capital to Bulgarian medium-sized enterprises to cope with the consequences of the COVID-19 pandemic.
Beneficiary: Neopharm Bulgaria Ltd.
Total value: BGN 150 000.00, of which BGN 127 500.00 European and BGN 22 500.00 national funding.
Start date: 01.02.2021.
End: 01.05.2021.
Primary objective: Supporting medium-sized enterprises to overcome the economic consequences of the COVID-19 pandemic, Providing operating capital to Bulgarian medium-sized enterprises to cope with the consequences of the COVID-19 pandemic.
Beneficiary: Neopharm Bulgaria Ltd.
Total value: BGN 150 000.00, of which BGN 127 500.00 European and BGN 22 500.00 national funding.
Start date: 01.02.2021.
End: 01.05.2021.
Project: Rebuilding SMEs through energy efficiency improvements
Procedure: BG16RFOP002-6.002
Beneficiary: Neopharm Bulgaria Ltd.
Start date: 16.09.2022
End: 16.03.2023
Total value: 287 500.00 BGN.
Grant: BGN 143 750.00 representing 100% European Regional Development Fund under REACT-EU
Objective: To improve energy efficiency in the Company by installing new air conditioning chambers.
Procedure: BG16RFOP002-6.002
Beneficiary: Neopharm Bulgaria Ltd.
Start date: 16.09.2022
End: 16.03.2023
Total value: 287 500.00 BGN.
Grant: BGN 143 750.00 representing 100% European Regional Development Fund under REACT-EU
Objective: To improve energy efficiency in the Company by installing new air conditioning chambers.